Thanks Marsuculix!

Here is a link to your post:

http://boards.fool.com/co-operation-with-roche-30299103.aspx...

Obviously, one could speculate more into this deal than there is but there continues to be "hints" of proof of concept with EXEL through the Roche collaboration, CABO response rates in various tumors.

I would also agree that with MTC FDA approval, that seems imminent, EXEL looks to be on more scientific sound footing.

It remains the financial and commercialization footing that still bothers many folks.